Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Jaguar Gene Therapy logo — Jaguar Gene Therapy is accelerating breakthroughs in gene th...

Jaguar Gene Therapy

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.

Founded 2019 United States Lake Forest, United States 48 employees Series Unknown Total: $139.00M Biotechnology

General Information

Company Name Jaguar Gene Therapy
Founded Year 2019
Location United States Lake Forest, United States +2
Founders / Decision Makers
Team member
Employees 48
Industries Biotechnology
Funding Stage Series Unknown
Social

Get notified when Jaguar Gene Therapy moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Jaguar Gene Therapy

Jaguar Gene Therapy, LLC, founded in 2019, is dedicated to accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases. With a team of experts possessing unparalleled CMC (Chemistry, Manufacturing and Controls), regulatory, clinical, and commercial acumen, Jaguar Gene Therapy is committed to patient safety and product purity. The company is rapidly advancing an initial pipeline of three programs targeting: 1) Type 1 galactosemia; 2) a genetic cause of autism spectrum disorder and Phelan-McDermid syndrome with a SHANK3 mutation or deletion; and 3) Type 1 diabetes. Moreover, Jaguar Gene Therapy continues to evaluate opportunities to expand its pipeline using the strength of the team and close relationships with numerous academic institutions. The company's recent Venture Round investment at 29 March 2022 was made by T1D Fund and Samsung Ventures. Positioned within the Biotechnology industry and headquartered in the United States, Jaguar Gene Therapy is gaining attention for its commitment to addressing severe genetic diseases and its potential to provide groundbreaking gene therapy solutions for a sizable patient population.

Taxonomy: Gene Therapy, Genetic Diseases, Type 1 galactosemia, Autism Spectrum Disorder, Phelan-McDermid Syndrome, Neurodevelopmental Disorders, SHANK3 Mutation, Type 1 Diabetes, CMC, Regulatory, Clinical Expertise, Commercial Acumen, Academic Institutions, Pipeline Expansion

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 2
Investor Investor
29 Mar 2022
Series B •••••• 6
Investor Investor Investor Investor
•••• •••• 		13 Apr 2021
Series A •••••• 1 •••• •••• 25 Feb 2021

Jaguar Gene Therapy Alternatives & Competitors

Jaguar Gene Therapy vs
uniQure
uniQure The Netherlands

Transforming the lives of patients through gene therapy

IPO
309 employees
Biotechnology, Pharmaceutical
Compare Jaguar Gene Therapy vs uniQure
Jaguar Gene Therapy vs
Orchard Therapeutics - U.S.
Orchard Therapeutics - U.S. United Kingdom

Dedicated to transforming the lives of patients with severe and other genetic diseases through innov...

Post Ipo Equity
239 employees
Biotechnology, Health Care
Compare Jaguar Gene Therapy vs Orchard Therapeutics - U.S.
Jaguar Gene Therapy vs
Bloomsbury Genetic Therapies
Bloomsbury Genetic Therapies United Kingdom

Dedicated to delivering the promise of gene therapy

Seed
2 employees
Biopharma, Biotechnology
Compare Jaguar Gene Therapy vs Bloomsbury Genetic Therapies

FAQ About Jaguar Gene Therapy

Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Jaguar Gene Therapy was founded in 2019.
Jaguar Gene Therapy is headquartered in Lake Forest, United States.
Jaguar Gene Therapy operates in the following industries: Biotechnology.
Jaguar Gene Therapy has approximately 48 employees.
Jaguar Gene Therapy has completed 3 funding rounds, raising a total of $139.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Jaguar Gene Therapy include uniQure, Orchard Therapeutics - U.S., Bloomsbury Genetic Therapies, AVROBIO, Atsena Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Jaguar Gene Therapy and uniQure are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Jaguar Gene Therapy and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes